Literature DB >> 17874135

Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.

Ajay P Sharma1, Cheryl R Greenberg, Asuri N Prasad, Chitra Prasad.   

Abstract

Diarrhea-positive hemolytic uremic syndrome (HUS) is a common cause of acute renal failure in children. Diarrhea-negative (D-), or atypical HUS, is etiologically distinct. A Medline search identified seven previously reported D- cases of HUS secondary to cobalamin C (cblC) disease presenting in infancy. An infantile presentation is reported to be associated with a high mortality rate (6/7 cases). We describe the results of a 5-year longitudinal follow-up in a child diagnosed with D- HUS secondary to cblC disease in infancy. Mutation analysis in this patient identified homozygosity for the 271 dupA mutation (c.271 dupA) in the cblC MMACHC gene. We briefly review the published experience in cblC-associated HUS to highlight the clinical characteristics of this uncommon, but potentially treatable, condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17874135     DOI: 10.1007/s00467-007-0604-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  35 in total

1.  Experimental production of renal glycosuria, phosphaturia, and aminoaciduria by injection of maleic acid.

Authors:  H E HARRISON; H C HARRISON
Journal:  Science       Date:  1954-10-15       Impact factor: 47.728

2.  Cobalamin C defect associated with hemolytic-uremic syndrome.

Authors:  M T Geraghty; E J Perlman; L S Martin; S J Hayflick; J F Casella; D S Rosenblatt; D Valle
Journal:  J Pediatr       Date:  1992-06       Impact factor: 4.406

3.  Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations.

Authors:  Chantal F Morel; Jordan P Lerner-Ellis; David S Rosenblatt
Journal:  Mol Genet Metab       Date:  2006-05-22       Impact factor: 4.797

4.  Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells.

Authors:  Michael Linnebank; Holger Lutz; Eva Jarre; Stefan Vielhaber; Carmen Noelker; Eduard Struys; Cornelis Jakobs; Thomas Klockgether; Bernd O Evert; Wolfram S Kunz; Ullrich Wüllner
Journal:  Neurobiol Dis       Date:  2006-07-28       Impact factor: 5.996

Review 5.  Cobalamin and folate deficiency: acquired and hereditary disorders in children.

Authors:  D S Rosenblatt; V M Whitehead
Journal:  Semin Hematol       Date:  1999-01       Impact factor: 3.851

6.  Progressive neurological deterioration and MRI changes in cblC methylmalonic acidaemia treated with hydroxocobalamin.

Authors:  G M Enns; A J Barkovich; D S Rosenblatt; D R Fredrick; K Weisiger; C Ohnstad; S Packman
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

7.  Methylmalonic acidemia: 6 years' clinical experience with two variants unresponsive to vitamin B12 therapy.

Authors:  D T Whelan; E Ryan; M Spate; M Morris; R M Hurley; R Hill
Journal:  Can Med Assoc J       Date:  1979-05-19       Impact factor: 8.262

8.  Optic atrophy in association with cobalamin C (cblC) disease.

Authors:  N Patton; S Beatty; I C Lloyd; J E Wraith
Journal:  Ophthalmic Genet       Date:  2000-09       Impact factor: 1.803

9.  Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.

Authors:  K A Hajjar
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Long-term outcome in treated combined methylmalonic acidemia and homocystinemia.

Authors:  H C Andersson; M Marble; E Shapira
Journal:  Genet Med       Date:  1999 May-Jun       Impact factor: 8.822

View more
  35 in total

1.  Introduction: education teaching article series on hemolytic uremic syndrome.

Authors:  Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

2.  Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene.

Authors:  Mehmet Gündüz; Filiz Ekici; Eda Özaydın; Serdar Ceylaner; Belen Perez
Journal:  Eur J Pediatr       Date:  2014-05-24       Impact factor: 3.183

3.  cblE-Type Homocystinuria Presenting with Features of Haemolytic-Uremic Syndrome in the Newborn Period.

Authors:  Daniel Palanca; Angels Garcia-Cazorla; Jessica Ortiz; Cristina Jou; Victoria Cusí; Mariona Suñol; Teresa Toll; Belén Perez; Aida Ormazabal; Brian Fowler; Rafael Artuch
Journal:  JIMD Rep       Date:  2012-07-21

Review 4.  Thrombotic microangiopathies: a general approach to diagnosis and management.

Authors:  Donald M Arnold; Christopher J Patriquin; Ishac Nazy
Journal:  CMAJ       Date:  2016-10-17       Impact factor: 8.262

5.  Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria.

Authors:  Francesca Menni; Sara Testa; Sophie Guez; Gabriella Chiarelli; Luisella Alberti; Susanna Esposito
Journal:  Pediatr Nephrol       Date:  2012-03-25       Impact factor: 3.714

Review 6.  Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.

Authors:  Marina A Morath; Friederike Hörster; Sven W Sauer
Journal:  Pediatr Nephrol       Date:  2012-07-20       Impact factor: 3.714

Review 7.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

8.  Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.

Authors:  James D Weisfeld-Adams; Mark A Morrissey; Brian M Kirmse; Bobbie R Salveson; Melissa P Wasserstein; Peter J McGuire; Sherlykutty Sunny; Jessica L Cohen-Pfeffer; Chunli Yu; Michele Caggana; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-09-27       Impact factor: 4.797

9.  CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency.

Authors:  Antonia H Bouts; Marcus T R Roofthooft; Gajja S Salomons; Jean-Claude Davin
Journal:  Pediatr Nephrol       Date:  2010-07-24       Impact factor: 3.714

10.  Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children.

Authors:  Qi-Liang Li; Wen-Qi Song; Xiao-Xia Peng; Xiao-Rong Liu; Le-Jian He; Li-Bing Fu
Journal:  World J Pediatr       Date:  2015-08-08       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.